Pharmaceutical Industry Blog

Last Updated: August 24, 2026 TL;DR: The Central African Republic is a humanitarian-led market with almost no domestic manufacturing and a regulatory system still being rebuilt. Medicines are overseen by the Ministere de la Sante et de la Population through its pharmaceutical services directorate, which issues marketing authorisations, licenses pharmaceutical establishments and controls importation through authorised ports of entry, but publishes no fee schedule, review clock

Last Updated: August 24, 2026 TL;DR: Liberia is a small, donor-supported market with an unusually clear rulebook. The Liberia Medicines and Health Products Regulatory Authority (LMHRA), established under the LMHRA Act of 2010, requires every medicine sold in the country to be registered, accepts dossiers in WAHO Common Technical Document format, grants registrations valid for three years and commits to processing applications within three months of acknowledged receipt and pa

Last Updated: August 23, 2026 TL;DR: Lebanon imports roughly 70% of its medicines and registers every one of them at the Ministry of Public Health, where a Drug Registration Technical Committee reviews files built in CTD structure and a named Lebanese agent must appear in Module 1. Price is set as part of the marketing authorisation against a basket of seven European and seven Middle Eastern reference countries plus the country of origin, and imported generics are capped at u

Last Updated: August 23, 2026 TL;DR: Singapore is one of the most demanding pharmaceutical markets in Asia and one of the most rewarding to get right. The Health Sciences Authority (HSA) regulates therapeutic products under the Health Products Act 2007 and the Health Products (Therapeutic Products) Regulations 2016, was designated a WHO-Listed Authority for its medicines regulatory system on 26 October 2023, and had already attained WHO Maturity Level 4 in January 2022. For a

Last Updated: August 23, 2026 TL;DR: El Salvador is a price-capped, heavily import-dependent market that has just rebuilt its regulator. The Dirección Nacional de Medicamentos, created by the Ley de Medicamentos (Decreto Legislativo No. 1008 of 22 February 2012), was transformed into the Superintendencia de Regulación Sanitaria (SRS) with effect from 7 August 2024. Registration runs under the Central American regulation RTCA 11.03.59:18, adopted by Resolución No. 446-2021 (CO

Last Updated: August 23, 2026 TL;DR: The Republic of the Congo regulates medicines through the Direction de la Pharmacie et du Médicament (DPM), which sits inside the Ministère de la Santé et de la Population and was placed in its current form by Décret n° 2018-286 of 2 July 2018. Market entry runs on an Autorisation de Mise sur le Marché, filed in French, and every consignment then moves through a locally licensed grossiste répartiteur holding a per-shipment import authorisa